Aristotle University Of Thessaloniki (AUTH)
Μελέτη μυκήτων του στόματος σε ανοσοκατασταλμένα άτομα
Abstract
dc:descriptionThis study was designed in order to determine the oral yeast carriage related to CD4+ T cells count and viral load and their resistance rates to several antifungal drugs. For that purpose we studied C.albicans and other Candida isolated from cultures of oropharyngeal samples obtained from human immunodeficiency virus –infected and healthy persons in Thessaloniki, Greece. We examined samples from 225 HIV positive patients and 39 HIV negative patients. Isolates were thawed and sub cultured onto CHROMagar Candida. Identification was confirmed by the use of commercially available kit API 20CAUX and when needed we used API ID32C. Susceptibility testing for the antifungal drugs amphotericin B, fluconazole, intraconazole, voriconazole was performed by the E-TEST. From the 291 isolates the 284 were C.albicans (97, 6%) and the rest 2.04% from other species such as C. krusei and C. tropicalis. According to the results we conclude that: 1) Oral carriage of Candida (candidosis is the first manifestation) in HIV-positive patients is common but not significantly more common than in healthy people. 2) C. albicans is the most common Candida isolated from the oropharynx of HIV-positive patients. 3) The presence of fungi and fungal lesions in the oropharynx is a reliable index of the HIV positive status in association with the viral load and the patient’s immune system. The appearance of fungal oral lesions means an increase of the viral load and a possible decrease of the CD4+ T lymphocytes. 4) The total number of the CD4+ T lymphocytes is not the most reliable index for the prognosis of candidosis of the oropharynx and the appearance of opportunistic infections in the HAART era. 5) The viral load is in inverse ratio with the appearance of fungal lesions of the oropharynx and it is considered the most reliable and sensitive index when it comes to oropharyngeal candidiasis. 6) HAART is associated with oropharyngeal candidiasis specially in patients with viral load more than 10000 cop/ml. 7) The tolerance to antifungal drugs is still in a good level with the exception of C. krusei which needs to be treated with either Voriconazole or amphotericine B. 8) Prophylactic antifungal chemotherapy didn’t prevent the occurrence of oropharyngeal candidiasis. 9) We need to be careful in administrating antifungal drugs which belong to the group of azoles as a precaution because of the increase in resistance in these drugs but also in the prevalence of species of Candida other than C. albicans.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agathaggelidis, Agathaggelos
- Αγαθαγγελίδης, Αγαθάγγελος
Subjects
dc:subject × 15- Καντιντίαση, Στοματοφαρυγγική
- Ιός ανθρώπινης ανοσοανεπάρκειας
- Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας - AIDS
- Φάρμακα, Αντιμυκητιακά
- CD4+ Τ - λεμφοκύτταρα
- Oropharyngeal candidiasis
- HIV
- AIDS disease
- Drugs, Antifungal
- Viral load
- CD4+ T lymphocytes
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19625